查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587463

心臟疾病诊断影像设备市场规模、份额、趋势分析报告：按模式、按地区、细分市场预测，2025-2030年

Coronary Heart Disease Diagnostic Imaging Device Market Size, Share & Trends Analysis Report By Modality (Computed Tomography, X-rays, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

心臟疾病诊断影像设备市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球心臟疾病诊断影像设备市场规模将达29.6亿美元，2025年至2030年复合年增长率为6.6%。

冠状动脉疾病和相关死亡率的增加需要更好、更早的诊断。准确的扫描解释和技术先进的设备是影响市场成长的因素。各种影像方式可用于识别冠状动脉筛检的独特方面。例如，血管内超音波、X射线血管造影术和电脑断层扫描（CTCA）直接评估和量化冠状动脉的变化。然而，单光子电脑断层扫描 (SPECT) 和正子断层扫描 (PET) 等非侵入性技术可以透过估计冠状动脉疾病导致的心肌灌注和代谢异常来改善冠状动脉疾病。

该领域的技术进步促进了由使用碲化镉锌 (CZT) 半导体检测器的伽马系统组成的Sharp Corporation相机单元的发展。与传统的基于 SPECT 的心肌灌注成像相比，这可以实现更快的影像撷取、更短的成像时间、更高的影像品质和更低的辐射剂量（每次注射 1 mSv）。此外，电脑断层扫描的改进促进了非侵入性技术的发展，这也预示着该领域的未来成长。然而，财务障碍、学科素养和医务人员短缺阻碍了将这种先进技术引入现实临床实践。

由于COVID-19大流行的爆发，2020年心臟疾病成像设备市场大幅下滑。对病毒传播的担忧、重点转向诊断和治疗 COVID-19 患者、其他疾病的住院率降低以及医务人员减少导致 CVD 诊断率下降。最终用户观察到的经济挫折也影响了采用先进技术来有效诊断冠状动脉变化。此外，因国家停工导致的製造设备停工、物流暂停、销售人员减少等也对市场产生了负面影响。

心臟疾病诊断影像设备市场报告亮点：

  • 核子医学因其易于影像解释和高检测精度而在医疗器材领域占据主导地位。
  • 电脑断层扫描的优点是可以及早检测出使用传统 SPECT 技术无法检测到的复杂变化，并且预计在预测期内将具有最快的复合年增长率。
  • 由于研发活动的活性化和经销商数量的增加，预计亚太地区在预测期内将以显着的复合年增长率成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章心臟疾病诊断影像设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 心臟疾病诊断影像设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 管道分析

第四章心臟疾病诊断设备市场：模态估计与趋势分析

  • 全球心臟疾病诊断影像设备市场：模态仪表板
  • 全球心臟疾病诊断影像设备市场：模态变异分析
  • 全球心臟疾病诊断影像设备市场：按模式分類的收益
  • 电脑断层扫描
  • X射线
  • 超音波
  • 磁振造影
  • 核子医学

第五章心臟疾病诊断影像设备市场：按模态分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争状况

  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2024年主要企业市场占有率分析
    • GE Healthcare
    • Koninklijke Phillips NV
    • Canon
    • Siemens Healthineers AG
    • Ziehm Imaging GmbH
    • Esaote SPA
    • Hitachi Medical Corporation
    • SAMSUNG
    • FUJIFILM Holdings Corporation
Product Code: GVR-4-68039-924-2

Coronary Heart Disease Diagnostic Imaging Devices Market Growth & Trends:

The global coronary heart disease diagnostic imaging device market size is expected to reach USD 2.96 billion by 2030, registering a CAGR of 6.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increase in coronary diseases and deaths associated with it calls for better and early diagnosis of the condition. Precise scan interpretation and technologically advanced equipment are the factors influencing the market growth. Various imaging modalities are useful in identifying unique aspects of coronary screening. For instance, intravascular ultrasound, X-ray angiography, and computed tomography angiography (CTCA) provide a direct evaluation and quantification of alterations in the coronary arteries. However, non-invasive techniques like single-photon computed tomography (SPECT) and positron emission tomography (PET) provide indirect information on CHD by estimating the myocardial perfusion and metabolism abnormalities that are consequent of coronary artery disease.

Technological advancement in this field had led to the development of sharp camera units consisting of gamma systems, that use semiconductor detectors of cadmium zinc telluride (CZT). This led to faster acquisition of images, reduced capture time, high image quality, and lower radiation dose (1mSv for a single injection), as compared to conventional myocardial perfusion imaging by SPECT. Further, improvements around Computed Tomography, to develop non-invasive techniques have also shown great future growth in this segment. However, economic barriers, subject literacy, and lack of medical staff hold back the implementation of such advanced techniques in real practice.

The coronary heart disease diagnostic imaging devices market saw a sharp decline in 2020, due to the outbreak of the COVID-19 pandemic. Fear of virus spread, the shift in focus on diagnosing and treating COVID-19 affected patients, reduced admission rates at hospitals for other diseases, and reduced medical staff, led to the reduction in the diagnosis of CVD. Economic setback observed by end-users also influenced the adoption of advanced techniques to effectively diagnoses coronary alterations. Further, the shutting down of manufacturing units, due to national lockdowns, halt in logistics, and reduction in salesforce also impacted the market negatively.

Coronary Heart Disease Diagnostic Imaging Devices Market Report Highlights:

  • Nuclear medicine dominated the modality segment due to the ease of image interpretation and accuracy in detection.
  • Computed tomography is anticipated to experience at the fastest CAGR o vefr the forecast period, due to its advantages of early detection of even the most intricate alterations which otherwise is impossible to det4ect in the traditional SPECT technology.
  • Asia Pacific is anticipated to be growing at a significant CAGR over the forecast period owing to the increase in R&D activities and numerous resellers.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary Heart Disease Diagnostic Imaging Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing Prevalence Of Coronary Artery Diseases
      • 3.2.1.2. Rising Adoption Of Early Diagnostic Techniques
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of Skilled Radiologists
  • 3.3. Coronary Heart Disease Diagnostic Imaging Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Coronary Heart Disease Diagnostic Imaging Device Market: Modality Estimates & Trend Analysis

  • 4.1. Global Coronary Heart Disease Diagnostic Imaging Device Market: Modality Dashboard
  • 4.2. Global Coronary Heart Disease Diagnostic Imaging Device Market: Modality Movement Analysis
  • 4.3. Global Coronary Heart Disease Diagnostic Imaging Device Market by Modality, Revenue
  • 4.4. Computed Tomography
    • 4.4.1. Computed Tomography market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. X rays
    • 4.5.1. X rays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Ultrasound
    • 4.6.1. Ultrasound market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Magnetic Resonance Imaging
    • 4.7.1. Magnetic Resonance Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Nuclear Medicine
    • 4.8.1. Nuclear Medicine market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Coronary Heart Disease Diagnostic Imaging Device Market: Regional Estimates & Trend Analysis by Modality

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. List of key distributors and channel partners
    • 6.2.2. Key customers
    • 6.2.3. Key company market share analysis, 2024
    • 6.2.4. GE Healthcare
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Koninklijke Phillips N.V.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Canon
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Siemens Healthineers AG
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Ziehm Imaging GmbH
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Esaote SPA
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Hitachi Medical Corporation
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. SAMSUNG
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. FUJIFILM Holdings Corporation
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 4 US Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 5 Canada Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 6 Mexico Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 7 Europe Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 9 Germany Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 10 UK Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 11 France Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 12 Italy Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 13 Spain Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 14 Denmark Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 15 Sweden Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 16 Norway Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 19 China Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 20 Japan Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 21 India Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 22 South Korea Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 23 Australia Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 24 Thailand Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 25 Latin America Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Latin America Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 27 Brazil Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 28 Argentina Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 29 MEA Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 31 South Africa Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 33 UAE Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 34 Kuwait Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Coronary heart disease diagnostic imaging devices market: market outlook
  • Fig. 14 Coronary heart disease diagnostic imaging devices competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Coronary heart disease diagnostic imaging devices market driver impact
  • Fig. 18 Coronary heart disease diagnostic imaging devices market restraint impact
  • Fig. 19 Coronary heart disease diagnostic imaging devices market: Modality movement analysis
  • Fig. 20 Coronary heart disease diagnostic imaging devices market: Modality outlook and key takeaways
  • Fig. 21 Computed Tomography market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 X rays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Ultrasound market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Magnetic resonance imaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Nuclear medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global Coronary heart disease diagnostic imaging devices market: Regional movement analysis
  • Fig. 27 Global Coronary heart disease diagnostic imaging devices market: Regional outlook and key takeaways
  • Fig. 28 Global Coronary heart disease diagnostic imaging devices market share and leading players
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 US key country dynamics
  • Fig. 31 US market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada key country dynamics
  • Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico key country dynamics
  • Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK key country dynamics
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany key country dynamics
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France key country dynamics
  • Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy key country dynamics
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Spain key country dynamics
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark key country dynamics
  • Fig. 48 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden key country dynamics
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Norway key country dynamics
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 China key country dynamics
  • Fig. 55 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan key country dynamics
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India key country dynamics
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand key country dynamics
  • Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea key country dynamics
  • Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Australia key country dynamics
  • Fig. 65 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil key country dynamics
  • Fig. 68 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina key country dynamics
  • Fig. 70 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa key country dynamics
  • Fig. 73 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia key country dynamics
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 UAE key country dynamics
  • Fig. 77 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait key country dynamics
  • Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Market share of key market players- Coronary heart disease diagnostic imaging devices market